Literature DB >> 14600654

Anti-Yo antibody-mediated paraneoplastic cerebellar degeneration in a man with esophageal adenocarcinoma.

Kai Xia1, John R Saltzman, David L Carr-Locke.   

Abstract

We report a case of paraneoplastic cerebellar degeneration (PCD) associated with adenocarcinoma of the esophagus and anti-Yo antibodies in a male patient. The patient presented with progressive ataxia, dysarthria, and significant weight loss. Extensive work-up suggested paraneoplastic neurologic syndrome. A wide search for a cancer was undertaken and a small mass was identified in the distal esophagus on upper endoscopy. Biopsies of this lesion revealed well-differentiated invasive adenocarcinoma of the esophagus. The endoscopic ultrasound staged the tumor as T3N1M0. Despite trials of multiple therapeutic modalities, the patient's cerebellar dysfunction progressed. This is only the second report of PCD caused by esophageal adenocarcinoma and the fourth report of anti-Yo antibodies occurring in a male patient.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14600654

Source DB:  PubMed          Journal:  MedGenMed        ISSN: 1531-0132


  3 in total

1.  Paraneoplastic cerebellar degeneration and anti-Yo antibodies in a man with prostatic adenocarcinoma.

Authors:  J Matschke; A Kromminga; A Erbersdobler; K Lamszus; S Anders; E Köfüncü
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-12-22       Impact factor: 10.154

Review 2.  Advances in Autoimmune Epilepsy Associated with Antibodies, Their Potential Pathogenic Molecular Mechanisms, and Current Recommended Immunotherapies.

Authors:  Zhiwei Fang; Yunqi Yang; Xuan Chen; Weiwang Zhang; Yangmei Xie; Yinghui Chen; Zhenguo Liu; Weien Yuan
Journal:  Front Immunol       Date:  2017-04-25       Impact factor: 7.561

3.  Anti-yo associated paraneoplastic cerebellar degeneration in a man with large cell cancer of the lung.

Authors:  Linda Hasadsri; James Lee; Bonnie H Wang; Lalitha Yekkirala; Mingtao Wang
Journal:  Case Rep Neurol Med       Date:  2013-09-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.